Independent Safety Committee approves the next cohort dosing of RECCE ® 327 (R327) at a faster infusion rate of 15 minutes of 3,000mg via intravenous (IV) administration R327 was shown to be safe and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results